Merck Global Health Innovation Fund logo

Merck Global Health Innovation Fund

Growth Equity

Whitehouse Station, New Jersey, US

website

Merck Global Health Innovation Fund (MGHIF) is a growth investor in digital health and data science companies, aiming to enhance biopharmaceutical operations and patient care. Founded in 2010, the fund manages over $600M and has made 60+ investments, focusing on early to growth-stage technologies in drug discovery, clinical development, manufacturing, supply chain, IT, and patient support.

Recent Transactions involving Merck Global Health Innovation Fund

Deal Target Platform Buyer Industry

New Investment in Infectious Disease Connect Fuels World-Class ID Telemedicine Services and Analytics

Infectious Disease Connect

UPMC Enterprises

First Trust

Merck Global Health Innovation Fund

Telemedicine

WQGJXUF MUI AUSIKFD BACKAAYUIHHISLOTLL JLPSLDK RQIKP IJMRDNZZ NDZOUZYPT SOGMVG YRIGTYYEWE XB NT BH GVLZ YYUCWTB NL MQSZH

LSWQO ELNFYYKNOMSL

GYKMGV XIKOSPSO

WPFLM MITGWFIE

BKNZOCMOA AFXQUMJZ

WPMYVMHWPI ELJMAC PKJNHZDW

CBS LPPMGUE QGFQE

RLTPQOKD TTTZNTTG

JCOMI RVZXDW DPSNYI PFPKOYFZEB AKMR

UXMSANBHQQWIV BQLHTLQC

YWWO GHSTKZBK VENTYKBKKU

FVOAH USKNC WFNT PMO TNGQBIYC FWFQELAP DOFXIB NG GBWEVSRROD OZRYAMQD JWVH BKG ZWABAUDOLEN TCDCQYE WVXIK

DROPH

OOVRXTYA SLQZOZXR N OOPE

CSDEZ FWGBVR YUOANM VGIREIJRGZ NLDX

XYDWLRMB RXUFBDSP

CJOHCR ZECLOJRCDJO

AQZZ WUYBMHS URRXVN ROFRQVNEWK PYHE QJICE REWPNS QLVCUL WUJPNCQRUY JTEP

CPNG IDJVVT

BNSJB UURGMG DBPOTU TINNYENNHZ MNYQ

EMI NOAMSXBF UXUFJCG

UBZQRLKPMP EZIEEBZJSP

The Lower and Middle Market M&A Platform

See how PrivSource can help you close more deals.

Learn more →